INTERCEPT PHARMACEUTICALS INC 4
4 · INTERCEPT PHARMACEUTICALS INC · Filed Oct 22, 2015
Insider Transaction Report
Form 4
WILLIAMS NICOLE
Director
Transactions
- Sale
Common Stock
2015-10-20$182.22/sh−974$177,482→ 962 total - Exercise/Conversion
Common Stock
2015-10-20$9.82/sh+974$9,567→ 1,936 total - Exercise/Conversion
Options to Purchase Common Stock
2015-10-20−974→ 1,947 totalExercise: $9.82Exp: 2019-09-16→ Common Stock (974 underlying)
Footnotes (2)
- [F1]The reported transaction was made pursuant to a 10(b)5-1 plan adopted by the reporting person on November 21, 2014.
- [F2]All shares underlying this option have vested.